BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 2441854)

  • 1. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
    Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
    Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens.
    Matsunaga A; Kuroki M; Higuchi H; Arakawa F; Takakura K; Okamoto N; Matsuoka Y
    Cancer Res; 1987 Jan; 47(1):56-61. PubMed ID: 2431767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
    Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
    Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
    Burtin P; Chavanel G; Hendrick JC; Frenoy N
    J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.
    Kuroki M; Arakawa F; Higuchi H; Matsunaga A; Okamoto N; Takakura K; Matsuoka Y
    Jpn J Cancer Res; 1987 Apr; 78(4):386-96. PubMed ID: 2438262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C; Clark BR; Rickard KJ; Shively JE
    J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
    Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker.
    Kuroki M; Matsushita H; Matsumoto H; Hirose Y; Senba T; Yamamoto T
    Anticancer Res; 1999; 19(6C):5599-606. PubMed ID: 10697625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of carcinoembryonic antigen-specific monoclonal antibodies and specific carcinoembryonic antigen assay in sera of patients.
    Kitagawa H; Ohkouchi E; Fukuda A; Imai K; Yachi A
    Jpn J Cancer Res; 1986 Sep; 77(9):922-30. PubMed ID: 2429946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
    Frénoy N; Schauffler J; Cahour A; Burtin P
    Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products.
    Hefta LJ; Schrewe H; Thompson JA; Oikawa S; Nakazato H; Shively JE
    Cancer Res; 1990 Apr; 50(8):2397-403. PubMed ID: 2317824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel tumor-associated Mr 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen.
    Shimada S; Ogawa M; Schlom J; Greiner JW
    Cancer Res; 1991 Oct; 51(20):5694-703. PubMed ID: 1913687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.
    Kuroki M; Ichiki S; Kuroki M; Matsuoka Y
    J Natl Cancer Inst; 1982 Aug; 69(2):401-8. PubMed ID: 6810002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies.
    Primus FJ; Newell KD; Blue A; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):686-92. PubMed ID: 6184152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
    Matsuoka Y; Kuroki M; Koga Y
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):575-84. PubMed ID: 6192762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.
    Verstijnen CP; Arends JW; Moerkerk PT; Warnaar S; Hilgers J; Bosman FT
    Anticancer Res; 1986; 6(1):97-104. PubMed ID: 2420267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.